Mechanistic insights into chemotherapy-induced circadian disruption using rodent models
Authors:
- 22 January 2025
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 48 (4) , 283-296
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute (R01CA270372)
This publication has 90 references indexed in Scilit:
- A Comprehensive Overview on Chemotherapy-Induced Cardiotoxicity: Insights into the Underlying Inflammatory and Oxidative MechanismsCardiovascular Drugs and Therapy, 2024
- Anthracycline-free tumor elimination in mice leads to functional and molecular cardiac recovery from cancer-induced alterations in contrast to long-lasting doxorubicin treatment effectsBasic Research in Cardiology, 2021
- Evaluation and Management of Sleep and Circadian Rhythm Disturbance in CancerCurrent Treatment Options in Oncology, 2021
- Circadian Variation in Efficacy of MedicationsClinical Pharmacology & Therapeutics, 2020
- Doxorubicin persistently rewires cardiac circadian homeostasis in miceArchives of Toxicology, 2019
- Phenotyping Circadian Rhythms in MiceCurrent Protocols in Mouse Biology, 2015
- Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancerCancer Chemotherapy and Pharmacology, 2015
- A role for orexin in cytotoxic chemotherapy-induced fatigueBrain, Behavior, and Immunity, 2014
- Prediction of overall survival through circadian rest‐activity monitoring during chemotherapy for metastatic colorectal cancerInternational Journal of Cancer, 2012
- Circadian rhythms in the rat: Constant darkness, entrainment to T cycles and to skeleton photoperiodsPhysiology & Behavior, 1983